Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 2 |
2020 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
An update on emerging drugs in osteosarcoma: towards tailored therapies?
Expert Opin Emerg Drugs. 2019 Sep;24(3):153-171. doi: 10.1080/14728214.2019.1654455. Epub 2019 Aug 14.
Expert Opin Emerg Drugs. 2019.
PMID: 31401903
Review.
Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments?
Hattinger CM, Patrizio MP, Tavanti E, Luppi S, Magagnoli F, Picci P, Serra M.
Hattinger CM, et al. Among authors: luppi s.
Expert Rev Mol Diagn. 2018 Nov;18(11):947-961. doi: 10.1080/14737159.2018.1535903. Epub 2018 Oct 19.
Expert Rev Mol Diagn. 2018.
PMID: 30324828
Review.
Item in Clipboard
Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact.
Hattinger CM, Patrizio MP, Luppi S, Serra M.
Hattinger CM, et al. Among authors: luppi s.
Int J Mol Sci. 2020 Jun 30;21(13):4659. doi: 10.3390/ijms21134659.
Int J Mol Sci. 2020.
PMID: 32629971
Free PMC article.
Review.
Item in Clipboard
Current understanding of pharmacogenetic implications of DNA damaging drugs used in osteosarcoma treatment.
Hattinger CM, Patrizio MP, Luppi S, Magagnoli F, Picci P, Serra M.
Hattinger CM, et al. Among authors: luppi s.
Expert Opin Drug Metab Toxicol. 2019 Apr;15(4):299-311. doi: 10.1080/17425255.2019.1588885. Epub 2019 Mar 18.
Expert Opin Drug Metab Toxicol. 2019.
PMID: 30822170
Review.
Item in Clipboard
Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing.
Hattinger CM, Casotti C, Patrizio MP, Luppi S, Fantoni L, Scotlandi K, Ibrahim T, Serra M.
Hattinger CM, et al. Among authors: luppi s.
Int J Mol Sci. 2022 Oct 4;23(19):11787. doi: 10.3390/ijms231911787.
Int J Mol Sci. 2022.
PMID: 36233089
Free PMC article.
Item in Clipboard
Single-nucleotide polymorphism profiling by multimodal-targeted next-generation sequencing in methotrexate-resistant and -sensitive human osteosarcoma cell lines.
Casotti C, Hattinger CM, Patrizio MP, Luppi S, Fantoni L, Pasello M, Scotlandi K, Ibrahim T, Serra M.
Casotti C, et al. Among authors: luppi s.
Front Pharmacol. 2023 Nov 22;14:1294873. doi: 10.3389/fphar.2023.1294873. eCollection 2023.
Front Pharmacol. 2023.
PMID: 38074116
Free PMC article.
Item in Clipboard
Cisplatin Resistance in Osteosarcoma: In vitro Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored Treatments.
Fanelli M, Tavanti E, Patrizio MP, Vella S, Fernandez-Ramos A, Magagnoli F, Luppi S, Hattinger CM, Serra M.
Fanelli M, et al. Among authors: luppi s.
Front Oncol. 2020 Mar 10;10:331. doi: 10.3389/fonc.2020.00331. eCollection 2020.
Front Oncol. 2020.
PMID: 32211337
Free PMC article.
Item in Clipboard
Cite
Cite